SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study

OBJECTIVE: To evaluate the performance of new lateral flow immunoassays (LFIAs) suitable for use in a national coronavirus disease 2019 (covid-19) seroprevalence programme (real time assessment of community transmission 2—React 2). DESIGN: Diagnostic accuracy study. SETTING: Laboratory analyses were...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshe, Maya, Daunt, Anna, Flower, Barnaby, Simmons, Bryony, Brown, Jonathan C, Frise, Rebecca, Penn, Rebecca, Kugathasan, Ruthiran, Petersen, Claire, Stockmann, Helen, Ashby, Deborah, Riley, Steven, Atchison, Christina, Taylor, Graham P, Satkunarajah, Sutha, Naar, Lenny, Klaber, Robert, Badhan, Anjna, Rosadas, Carolina, Marchesin, Federica, Fernandez, Natalia, Sureda-Vives, Macià, Cheeseman, Hannah, O’Hara, Jessica, Shattock, Robin, Fontana, Gianluca, Pallett, Scott J C, Rayment, Michael, Jones, Rachael, Moore, Luke S P, Ashrafian, Hutan, Cherapanov, Peter, Tedder, Richard, McClure, Myra, Ward, Helen, Darzi, Ara, Elliott, Paul, Cooke, Graham S, Barclay, Wendy S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921617/
https://www.ncbi.nlm.nih.gov/pubmed/33653694
http://dx.doi.org/10.1136/bmj.n423

Ejemplares similares

Ejemplares similares